Dicerna Pharmaceuticals, Inc. Appoints Shreeram Aradhye as Executive Vice President and Chief Medical Officer, Effective Sept. 8, 2020
August 05, 2020 at 04:05 pm
Dicerna Pharmaceuticals, Inc. announced that Shreeram Aradhye, M.D., will become Dicerna’s executive vice president and chief medical officer (CMO) and a member of the Company’s executive leadership team, effective Sept. 8, 2020. Dr. Aradhye’s appointment follows the previously announced retirement of Ralf Rosskamp, M.D., who will continue with the Company in a consulting capacity at least through the end of June 2021. Dr. Aradhye joins Dicerna from Axcella Health, where he has served as executive vice president and chief development officer and a member of the executive team with direct oversight of clinical development, regulatory affairs, QA and scientific communications.